Dr. Rachid Karam obtained his M.D. in 2003 in Brazil at the Universidade Federal de Ciencias da Saude de Porto Alegre (UFCSPA), and his Ph.D. in oncogenetics in 2008, at the University of Porto, Portugal. He did his postdoctoral studies at the University of California, San Diego, from 2009 to 2014. He joined Ambry Genetics in 2014 and is now Ambry’s director of translational and clinical research